LAURA LONG: Open Payments
NPI 1528067196 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 8 payments from 5 companies in 2025. Trend: 2023 $161 · 2024 $317 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 1 | $107 |
| Eisai Inc. | 3 | $87 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Hologic Sales and Service, LLC | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $21 |
Products named: Tivdak, Lenvima, KEYTRUDA, FLUENT FLUID MANAGEMENT SYSTEM, Attruby.
Industry payments across IN — which companies pay providers there.
